Table 2.

Clinicopathological Data in Relation to the Diagnosis (n=57)

Variables	Diagnosis			P value
	Benign	Borderline	Malignant
	n (%)	n (%)	n (%)
Clinical Data
Age				>0.950
Less than 20	3 (100.0)	0 (0.0)	0 (0.0)
More than 20	39 (72.2)	9 (16.7)	6 (11.1)
Race				>0.950
Malay	41 (73.2)	9 (16.1)	6 (10.7)
Chinese	1 (00.0)	0 (0.0)	0 (0.0)
Treatment				<0.001
Defaulted	6 (85.7)	1 (14.3)	0 (0.0)
Lumpectomy	27 (93.1)	2 (6.9)	0 (0.0)
Mastectomy	3 (25.0)	4 (33.3)	5 (41.7)
WLE	6 (66.7)	2 (22.2)	1 (11.1)
Skin changes				0.004
No	38 (80.9)	7 (14.9)	2 (4.3)
Yes	4 (40.0)	2 (20.0)	4 (40.0)
Lump size				0.052
Less 3 cm	24 (88.9)	2 (7.4)	1 (3.7)
More 3 cm	18 (60.0)	7 (23.3)	5 (16.7)
Histopathological examination (HPE)
Atypia				<0.001
Yes	4 (22.2)	8 (44.4)	6 (33.3)
No	38 (97.4)	1 (2.6)	0 (0.0)
Stromal hypercellularity				0.012
No	26 (86.7)	4 (13.3)	0 (0.0)
Yes	16 (59.3)	5 (18.5)	6 (22.2)
Stromal overgrowth				0.33
No	12 (92.3)	1 (7.7)	0 (0.0)
Yes	30 (68.2)	8 (18.2)	6 (13.6)
Mitosis				<0.001
<5	42 (93.3)	3 (6.7)	0 (0.0)
5-9	0 (0.0)	6 (85.7)	1 (14.3)
>9	0 (0.0)	0 (0.0)	5 (100.0)
Immunohistochemistry (IHC)
Ki67				<0.001
Negative/mild	42 (82.4)	9 (17.6)	0 (0.0)
Mod	0 (0.0)	0 (0.0)	2 (100.0)
Mark	0 (0.0)	0 (0.0)	4 (100.0)
p53				<0.001
Negative/mild	32 (94.1)	2 (5.9)	0 (0.0)
Mod	10 (58.8)	4 (23.5)	3 (17.6)
Mark	0 (0.0)	3 (50.0)	3 (50.0)